The United Laboratories International Holdings Limited (HKG:3933)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
9.07
-0.03 (-0.33%)
Aug 11, 2026, 3:59 PM HKT

HKG:3933 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
13,21113,21113,75913,74011,3349,703
Revenue Growth
-6.32%-3.98%0.14%21.22%16.81%10.61%
Gross Profit
5,5145,5146,0826,3354,9694,211
Operating Income
2,2222,2222,8193,1672,0151,382
Net Income
2,0862,0862,6602,7011,581988.1
Earnings Per Share
1.111.111.461.490.870.54
EPS Growth
-34.36%-24.41%-1.53%71.11%61.80%34.90%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Intermediate Products
4,0184,0185,8575,7534,3183,385
Bulk Medicine
5,8935,8937,3527,3926,0454,554
Finished Products
6,6986,6984,7285,0244,5604,035
Elimination
-3,398-3,398-4,178-4,429-3,589-2,270
Total
13,21113,21113,75913,74011,3349,703

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
10,60610,6066,3304,2624,7433,331
Total Debt
4,9924,9923,1561,5042,4631,848
Net Cash (Debt)
5,6155,6153,1742,7582,2801,483
Net Cash Growth
44.39%76.89%15.07%20.96%53.75%89.92%
Net Cash Per Share
2.982.981.751.521.250.81

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
3,7503,7503,1992,4392,0311,543
Capital Expenditures
-2,802-2,802-1,715-1,274-779.55-482.17
Free Cash Flow
947.32947.321,4841,1651,2511,060
Free Cash Flow Growth
28.99%-36.17%27.40%-6.88%17.98%2.25%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
41.74%41.74%44.21%46.11%43.84%43.40%
Operating Margin
16.82%16.82%20.49%23.05%17.78%14.24%
Pretax Margin
19.14%19.14%23.90%24.34%17.71%12.39%
Profit Margin
15.79%15.79%19.33%19.66%13.95%10.18%
FCF Margin
7.17%7.17%10.79%8.48%11.04%10.93%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.4880.4200.4400.4000.1900.120
Dividend Per Share Growth
-51.22%-4.54%10.00%110.53%58.33%50.00%
Dividend Yield
5.29%4.16%4.07%7.29%5.35%4.30%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
7.399.857.944.284.986.58
Forward PE
11.137.256.835.636.085.41
P/FCF Ratio
17.0221.6914.229.936.306.13
PS Ratio
1.221.561.530.840.700.67